Literature DB >> 9286695

Genomic organization of two novel genes on human Xq28: compact head to head arrangement of IDH gamma and TRAP delta is conserved in rat and mouse.

V Brenner1, G Nyakatura, A Rosenthal, M Platzer.   

Abstract

In this paper we present the entire genomic sequence as well as the cDNA sequence of two new human genes encoding the gamma subunit of the NAD(+)-dependent isocitrate dehydrogenase (H-IDH gamma) and the translocon-associated protein delta subunit (TRAP delta). These genes are located on region q28 of the human X chromosome, approximately 70 kb telomeric to the adrenoleukodystrophy locus (ALD). The sequences of the transcripts of both genes were obtained by searching the EST database with genomic data. Identified ESTs were completely sequenced and assembled to cDNAs comprising the entire coding region. For IDH gamma, several EST clones indicate differential splicing. IDH gamma and TRAP delta are arranged in a compact head to head manner. The nontranscribed intergenic region represents only 133 bp and is embedded in a CpG island. The CpG island obviously functions as a bidirectional promoter to initiate the transcription of both functionally unrelated genes with quite distinct expression patterns. This exceptional gene arrangement prompted us to clone and sequence genomic DNA fragments containing the homologous intergenic regions of rat and mouse. We show that in both species this area is similarly compact and represents less than 249 bp in rat and not more than 164 bp in mouse. In both cases this intergenic region is embedded in a CpG island and is highly conserved with nucleotide identity values ranging from 70.1% between human and rat to 92.6% between mouse and rat.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9286695     DOI: 10.1006/geno.1997.4822

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  8 in total

1.  Computational inference of homologous gene structures in the human genome.

Authors:  R F Yeh; L P Lim; C B Burge
Journal:  Genome Res       Date:  2001-05       Impact factor: 9.043

2.  Interleukin-1 receptor-associated kinase gene Il1rak maps to the mouse X chromosome.

Authors:  J M Centanni; M de Miguel; G Gopalan; D J Gilbert; N G Copeland; N A Jenkins; P J Donovan
Journal:  Mamm Genome       Date:  1998-04       Impact factor: 2.957

3.  Epstein-barr virus-induced changes in B-lymphocyte gene expression.

Authors:  Kara L Carter; Ellen Cahir-McFarland; Elliott Kieff
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

4.  A new congenital disorder of glycosylation caused by a mutation in SSR4, the signal sequence receptor 4 protein of the TRAP complex.

Authors:  Marie Estelle Losfeld; Bobby G Ng; Martin Kircher; Kati J Buckingham; Emily H Turner; Alexey Eroshkin; Joshua D Smith; Jay Shendure; Deborah A Nickerson; Michael J Bamshad; Hudson H Freeze
Journal:  Hum Mol Genet       Date:  2013-11-11       Impact factor: 6.150

5.  Differential gene expression in human conducting airway surface epithelia and submucosal glands.

Authors:  Anthony J Fischer; Kelli L Goss; Todd E Scheetz; Christine L Wohlford-Lenane; Jeanne M Snyder; Paul B McCray
Journal:  Am J Respir Cell Mol Biol       Date:  2008-08-14       Impact factor: 6.914

6.  Proteomic analysis identifies proteins associated with curcumin-enhancing efficacy of irinotecan-induced apoptosis of colorectal cancer LOVO cell.

Authors:  Da-Jian Zhu; Xiao-Wu Chen; Jia-Zhi Wang; Yong-Le Ju; Man-Zhao Ou Yang; Wei-Jie Zhang
Journal:  Int J Clin Exp Pathol       Date:  2013-12-15

7.  Genomic organization and linkage via a bidirectional promoter of the AP-3 (adaptor protein-3) mu3A and AK (adenosine kinase) genes: deletion mutants of AK in Chinese hamster cells extend into the AP-3 mu3A gene.

Authors:  Bhag Singh; Radhey S Gupta
Journal:  Biochem J       Date:  2004-03-01       Impact factor: 3.857

Review 8.  Biological Significance of Mutant Isocitrate Dehydrogenase 1 and 2 in Gliomagenesis.

Authors:  Shigeo Ohba; Yuichi Hirose
Journal:  Neurol Med Chir (Tokyo)       Date:  2016-03-10       Impact factor: 2.036

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.